Germany to receive 3.8 mln doses of Novavax

Discussion in 'Coronavirus (COVID-19) News' started by James California, Jan 26, 2022.

PF does not allow misinformation. However, please note that posts could occasionally contain content in violation of our policies prior to our staff intervening. We urge you to seek reliable alternate sources to verify information you read in this forum.

Tags:
  1. James California

    James California Well-Known Member Past Donor

    Joined:
    Nov 25, 2019
    Messages:
    11,373
    Likes Received:
    11,507
    Trophy Points:
    113
    Gender:
    Male
    Germany to receive 3.8 million doses of Novavax's new COVID vaccine
    Novavax Inc. COVID-19 vaccine showed adverse events were predominantly mild-to-moderate and transient and increased after the second dose. Severe reactions were infrequent and there were no safety concerns related to vaccination.
    Novavax Inc. COVID-19 vaccine is effective in generating an immune response against the Omicron variant, according to study data.


    ~ Hopefully this vaccine will perform better than the previous ones ...
     
    Last edited: Jan 26, 2022

Share This Page